John Chung-Kai Chan, M.D. , Scientist; Gynecologic Oncologist at CPMC

California Pacific CURRENTS: The online journal of CPMC Research Institute

New advances in the treatment of gynecologic cancers

Research Overview

  • Dr. Chan specializes in the surgical and medical treatment of ovarian and other pelvic cancers at CPMC. He is board certified in gynecologic oncology, and obstetrics and gynecology.
  • He is investigating new treatments for gynecologic cancers, including targeted biologic therapies, and exploring the role of tumor-initiating cells in ovarian cancer.
  • A clinician and surgeon, Dr. Chan is a principal investigator of studies assessing the treatment and health outcomes of ovarian and uterine cancer patients.
  • Dr. Chan is the Gynecologic Oncology Lead for the Sutter Cancer Research Consortium.
  • He is a Physician Lead in CPMCRI’s Cancer Avatar Project.

Listen to Dr. Chan's perspectives on gynecologic cancer care at Sutter Health.


Dr. Chan obtained his M.D. from Los Angeles School of Medicine in Los Angeles, California. While at the University of California at Irvine, he completed a residency in obstetrics and gynecology, and a fellowship in gynecologic oncology.


Publication Search


Kapp DS, Rosenfeld EB, Chan JE, Chan JK, Factors associated with oophorectomy in children with benign ovarian masses. Int J Gynaecol Obstet

Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS, Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol

de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y, B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. Am J Clin Pathol

Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES, EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. Am J Clin Pathol

Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y, Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol

Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y, T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. Am J Clin Pathol

John Chung-Kai Chan, M.D. , Scientist; Gynecologic Oncologist at CPMC
Primary Research Interests
  • Diagnosis and treatment of ovarian and pelvic cancers
  • Prognostic factors for high-risk, early stage epithelial ovarian cancer